Entity Common Stock, Shares Outstanding of INTEGRATED BIOPHARMA INC from 15 Nov 2011 to 11 Feb 2026

Taxonomy & unit
dei: shares
Description
Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.
Summary
INTEGRATED BIOPHARMA INC quarterly Entity Common Stock, Shares Outstanding in shares history and change rate from 15 Nov 2011 to 11 Feb 2026.
  • INTEGRATED BIOPHARMA INC Entity Common Stock, Shares Outstanding for the quarter ending 11 Feb 2026 was 31,059,610, a 2.5% increase year-over-year.
Source SEC data
View on sec.gov
Entity Common Stock, Shares Outstanding, Quarterly (shares)
Entity Common Stock, Shares Outstanding, YoY Quarterly Change (%)

INTEGRATED BIOPHARMA INC Quarterly Entity Common Stock, Shares Outstanding (shares)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q4 2025 31,059,610 +758,890 +2.5% 11 Feb 2026 10-Q 11 Feb 2026 2026 Q2
Q3 2025 31,059,610 +960,000 +3.2% 23 Sep 2025 10-K 23 Sep 2025 2025 FY
Q1 2025 30,300,720 +201,110 +0.67% 14 May 2025 10-Q 14 May 2025 2025 Q3
Q4 2024 30,300,720 +201,110 +0.67% 13 Feb 2025 10-Q 13 Feb 2025 2025 Q2
Q3 2024 30,099,610 +150,000 +0.5% 20 Sep 2024 10-K 20 Sep 2024 2024 FY
Q1 2024 30,099,610 +166,666 +0.56% 10 May 2024 10-Q 10 May 2024 2024 Q3
Q4 2023 30,099,610 +150,000 +0.5% 12 Feb 2024 10-Q 12 Feb 2024 2024 Q2
Q3 2023 29,949,610 0 0% 15 Sep 2023 10-K 15 Sep 2023 2023 FY
Q1 2023 29,932,944 0 0% 11 May 2023 10-Q 11 May 2023 2023 Q3
Q4 2022 29,949,610 +116,666 +0.39% 10 Feb 2023 10-Q 10 Feb 2023 2023 Q2
Q3 2022 29,949,610 +129,333 +0.43% 13 Sep 2022 10-K 13 Sep 2022 2022 FY
Q1 2022 29,932,944 +163,001 +0.55% 12 May 2022 10-Q 12 May 2022 2022 Q3
Q4 2021 29,832,944 +141,001 +0.48% 10 Feb 2022 10-Q 10 Feb 2022 2022 Q2
Q3 2021 29,820,277 +174,334 +0.59% 02 Sep 2021 10-K 02 Sep 2021 2021 FY
Q1 2021 29,769,943 +204,000 +0.69% 13 May 2021 10-Q 13 May 2021 2021 Q3
Q4 2020 29,691,943 +126,000 +0.43% 12 Feb 2021 10-Q 12 Feb 2021 2021 Q2
Q3 2020 29,645,943 +80,000 +0.27% 23 Sep 2020 10-K 23 Sep 2020 2020 FY
Q1 2020 29,565,943 0 0% 13 May 2020 10-Q 13 May 2020 2020 Q3
Q4 2019 29,565,943 0 0% 12 Feb 2020 10-Q 12 Feb 2020 2020 Q2
Q3 2019 29,565,943 +200,000 +0.68% 29 Aug 2019 10-K 29 Aug 2019 2019 FY
Q1 2019 29,565,943 +8,430,769 +40% 15 May 2019 10-Q 15 May 2019 2019 Q3
Q4 2018 29,565,943 +8,430,769 +40% 13 Feb 2019 10-Q 13 Feb 2019 2019 Q2
Q3 2018 29,365,943 +8,230,769 +39% 12 Sep 2018 10-K 12 Sep 2018 2018 FY
Q1 2018 21,135,174 +5,000 +0.02% 09 May 2018 10-Q 09 May 2018 2018 Q3
Q4 2017 21,135,174 +5,000 +0.02% 09 Feb 2018 10-Q 09 Feb 2018 2018 Q2
Q3 2017 21,135,174 +30,000 +0.14% 01 Sep 2017 10-K 01 Sep 2017 2017 FY
Q1 2017 21,130,174 +25,000 +0.12% 10 May 2017 10-Q 10 May 2017 2017 Q3
Q4 2016 21,130,174 +25,000 +0.12% 10 Feb 2017 10-Q 10 Feb 2017 2017 Q2
Q3 2016 21,105,174 0 0% 02 Sep 2016 10-K 02 Sep 2016 2016 FY
Q1 2016 21,105,174 0 0% 13 May 2016 10-Q 13 May 2016 2016 Q3
Q4 2015 21,105,174 12 Feb 2016 10-Q 19 Feb 2016 2016 Q2
Q3 2015 21,105,174 0 0% 04 Sep 2015 10-K 04 Sep 2015 2015 FY
Q1 2015 21,105,174 +25,000 +0.12% 17 Feb 2015 10-Q 17 Feb 2015 2015 Q2
Q3 2014 21,105,174 +25,000 +0.12% 08 Sep 2014 10-K 08 Sep 2014 2014 FY
Q1 2014 21,080,174 0 0% 14 May 2014 10-Q 14 May 2014 2014 Q3
Q4 2013 21,080,174 0 0% 12 Feb 2014 10-Q/A 13 Feb 2014 2014 Q2
Q3 2013 21,080,174 0 0% 30 Sep 2013 10-K 30 Sep 2013 2013 FY
Q1 2013 21,080,174 +100,000 +0.48% 15 May 2013 10-Q 15 May 2013 2013 Q3
Q4 2012 21,080,174 +115,100 +0.55% 14 Feb 2013 10-Q 19 Feb 2013 2013 Q2
Q3 2012 21,080,174 13 Oct 2012 10-K 15 Oct 2012 2012 FY
Q2 2012 21,030,174 21 May 2012 10-Q 21 May 2012 2012 Q3
Q1 2012 20,980,174 21 Feb 2012 10-Q 21 Feb 2012 2012 Q2
Q4 2011 20,965,074 15 Nov 2011 10-Q 21 Nov 2011 2012 Q1
* An asterisk sign (*) next to the value indicates that the value is likely invalid.